Synthetic Male Condom Slippage-Breakage Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

600 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-06-10

Study Completion Date

2023-05-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a multi-site, double-blind, crossover, randomized phase II study to evaluate the functional performance of a synthetic male condom as compared to a marketed latex condom.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of the Performance and Acceptability of a Synthetic Polyisoprene Male Condom Compared to a Natural Rubber Latex Condom

NCT06595836

Condom Use

RECRUITING NA

Clinical Study to Evaluate the Performance of Synthetic Polyurethane Male Condoms

NCT05536336

Performance of Synthetic Polyurethane Male Condom

TERMINATED NA

Evaluation of Synthetic Nitrile Male Condom Compared to Standard Latex Male Condom

NCT06079060

Sexually Transmitted Diseases

COMPLETED NA

Evaluation of 2 Synthetic Nitrile Male Condoms Compared to a Standard Latex Male Condom

NCT05912283

Sexually Transmitted Diseases

COMPLETED NA

Functionality of Male Condoms With a Silicone Elastomer Vaginal RIng

NCT01755741

Human Immunodeficiency Virus

COMPLETED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Approximately 300 heterosexual monogamous couples not at risk of pregnancy or transmission of sexually transmitted infections (STI) will be recruited to use both the test (synthetic) condom and a control (latex) condom. Couples will be given 4 condoms of one type (randomly determined) to use over a two week period, followed by 4 condoms of the other type to be used over the next two week period. The number of clinical failures (either condom breaks or completely slips off the penis) for each condom type will be compared to determine whether the test condom is non-inferior to the control condom. The study plan is based on International Standards Organization (ISO) guidance document ISO 29943-1 with the action standard set by synthetic condom standard ISO 23409.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Contraceptive Sexually Transmitted Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Each product will be labeled with a randomly generated code.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Test Product

Synthetic Male Condom

Group Type EXPERIMENTAL

Test Product

Intervention Type DEVICE

Synthetic Male Condom

Control Product

Latex Male Condom

Group Type ACTIVE_COMPARATOR

Control Product

Intervention Type DEVICE

Latex Male Condom

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Test Product

Synthetic Male Condom

Intervention Type DEVICE

Control Product

Latex Male Condom

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Synthetic Male Condom Latex Male Condom

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Willing and able to give written or electronic informed consent
* Willing to respond to questions concerning participant's reproductive and contraceptive history and use of condoms contained either on self-administered surveys or interviews
* Agree to have vaginal intercourse at least once weekly
* Protected against pregnancy by oral contraceptives, an intrauterine device (IUD), an implant, contraceptive injections, contraceptive patch, or sterilization (tubal ligation or vasectomy)
* Willing to use the study products for eight acts of vaginal intercourse within four weeks of study entry
* In a mutually monogamous relationship with participant's study partner for at least 3 months prior to screening and be willing to remain mutually monogamous throughout study participation
* Agree not to use any vaginal or sexual lubricant except the product supplied by the study (AstroglideTM)
* Agree not to wear any genital piercing jewellery while using the study condoms
* Agree not to use sex toys or drugs intended to enhance or diminish sexual response when using study condoms
* Agree to return any unopened condoms
* Reachable by telephone
* Has home internet access, a valid personal email for each partner, ability to videoconference and use electronic signature technology
* Male partner agrees to ejaculate during vaginal intercourse

Exclusion Criteria

* Currently participating in another similar clinical study or employed by a condom manufacturer or Essential Access Health
* Female partner self-reported as pregnant
* Allergic to natural rubber latex or styrene-isoprene-styrene (SIS), or has a history of recurrent adverse events following use of latex or SIS products
* Unable to follow instructions or strictly adhere to the visit schedule
* At significant (high) risk of sexually transmitted infections, including human immunodeficiency virus (HIV) infection or having a medical history of recurrent, serious sexually transmitted infection (e.g., gonorrhea, syphilis, Chlamydia)
* Currently using condoms for protection against a known sexually transmitted infection
* Taking any externally applied medication or oral medication to treat a genital condition
* Male partner has had difficulty achieving or maintaining an erection or achieving ejaculation in the last month prior to screening under typical circumstances/ conditions.
* Any self-reported genital condition (e.g., itching, burning, irritation, etc.) which, in the opinion of the investigator, could affect the use of the study condoms or the ability to interpret study data

Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes